Analyst Ratings for Companhia Brasileira de Distribuicao Grupo Pao de Acucar ADR (CBD)Updated: 2017-07-27
Companhia Brasileira de Distribuicao Grupo Pao de Acucar ADR (NYSE:CBD) was awarded an average rating of Overweight from investment analysts following the stock. A consensus rating of Overweight was previously issued for CBD last month.
A buy rating was issued by 8 analysts, 0 gave an overweight rating, 6 issued a hold rating, 0 gave an underweight rating, and 0 issued a sell rating. Today, there are 1 more analysts optimistic about the company future as compared with 90 days ago. Meanwhile, the number of analysts pessimistic about the company has increased by 0.
CBD was given price targets by several analysts. The most optimistic price target was 27.88, implying a possible profit of 22.77 percent. The most pessimistic analyst gave a price target of 21.17, implying potential capital losses of -6.78 percent. One must be careful with overanalyzing price targets and ratings due to possible conflicts of interest among the analysts releasing them.
In the last 30 days, analysts have changed their quarterly earnings estimates upwards by an average of 250 percent. The average change in earnings estimates over the last 90 days is 0 percent. Meanwhile, fiscal year estimates have been revised downwards by -0.94 percent, compared to last month. Expanding the time horizon to 3 months, the average change in fiscal year estimates becomes 1.14 percent.
Another thing investors often look at is the level of agreement among analysts' revisions. 1 analysts have revised their quarterly estimates upwards in the past 30 days, while 0 analysts revised their estimates downwards. During this time, 1 analysts made positive revisions in their estimates for this fiscal year's earnings, while 2 analysts decreased their estimates.
CBD has traded between a high of 24.75 and a low of 14.08 over the past year. The current market price is above the trailing year's low by 61.29 percent, and below the high by 8.24 percent. CBD has a price/earnings ratio of 0. Investors typically compare the P/E ratio to a company's peers in the industry. The CBD value stock report compares CBD to some of its peers using value stock charts. The stock has a market capitalization of $5.18 billion. CBD will post this quarters earnings in days, on 0000-00-00.